XML 20 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Results of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Sales and revenues:        
Total sales and revenues $ 13,510 $ 11,413 $ 40,380 $ 32,566
Operating costs:        
Cost of Revenue 9,022 7,678 27,010 22,295
Selling, general and administrative expenses 1,299 1,254 4,015 3,619
Research and development expenses 479 461 1,384 1,344
Interest expense of Financial Products 185 163 533 484
Other operating (income) expenses 390 348 1,028 1,751
Total operating costs 11,375 9,904 33,970 29,493
Operating profit 2,135 1,509 6,410 3,073
Interest expense excluding Financial Products 102 118 305 362
Other income (expense) 102 132 350 260
Consolidated profit before taxes 2,135 1,523 6,455 2,971
Provision (benefit) for income taxes 415 470 1,377 921
Profit of consolidated companies 1,720 1,053 5,078 2,050
Equity in profit (loss) of unconsolidated affiliated companies 7 8 21 8
Profit of consolidated and affiliated companies 1,727 1,061 5,099 2,058
Less: Profit (loss) attributable to noncontrolling interests 0 2 0 5
Profit [1] $ 1,727 $ 1,059 $ 5,099 $ 2,053
Profit per common share (in dollars per share) $ 2.92 $ 1.79 $ 8.57 $ 3.48
Profit per common share - diluted (in dollars per share) [2] $ 2.88 $ 1.77 $ 8.45 $ 3.44
Weighted-average common shares outstanding (millions)        
Basic (in shares) 592.1 592.9 595.3 590.3
Diluted (in shares) [2] 599.4 600.1 603.8 596.5
Cash dividends declared per common share (in dollars per share) $ 0.00 $ 0.00 $ 1.64 $ 1.55
Machinery, Energy & Transportation        
Sales and revenues:        
Total sales and revenues $ 12,763 $ 10,713 $ 38,192 $ 30,482
Financial Products        
Sales and revenues:        
Total sales and revenues $ 747 $ 700 $ 2,188 $ 2,084
[1] 1 Profit attributable to common shareholders.
[2] 2 Diluted by assumed exercise of stock-based compensation awards using the treasury stock method.